Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Capital One
COF
|
+$445M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$405M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$387M |
| 4 |
Johnson & Johnson
JNJ
|
+$256M |
| 5 |
Procter & Gamble
PG
|
+$170M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$536M |
| 2 |
NVIDIA
NVDA
|
+$471M |
| 3 |
X
US Steel
X
|
+$421M |
| 4 |
JPMorgan Chase
JPM
|
+$237M |
| 5 |
Deere & Co
DE
|
+$235M |
Sector Composition
| 1 | Technology | 20.97% |
| 2 | Financials | 18.52% |
| 3 | Industrials | 12.24% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Healthcare | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
3001
DELISTED
Inozyme Pharma
INZY
| $481K | ﹤0.01% |
120,145
-131,939
| -52% | -$528K |
|
3002
NCS Multistage Holdings
NCSM
$115M
| $481K | ﹤0.01% |
16,273
+1,195
| +8% | +$35.3K |
|
3003
Ventyx Biosciences
VTYX
$170M
| $480K | ﹤0.01% |
224,337
+32,497
| +17% | +$69.6K |
|
|
QIPT
3004
Quipt Home Medical
QIPT
$112M
| $479K | ﹤0.01% |
267,368
+84,504
| +46% | +$151K |
|
|
STKL
3005
SunOpta
STKL
$765M
| $477K | ﹤0.01% |
82,164
+56,819
| +224% | +$330K |
|
3006
NovoCure
NVCR
$1.41B
| $466K | ﹤0.01% |
26,154
+847
| +3% | +$15.1K |
|
3007
Bank Of The James
BOTJ
$70.4M
| $460K | ﹤0.01% |
32,665
+2,662
| +9% | +$37.5K |
|
|
FORTY
3008
Formula Systems
FORTY
$2.15B
| $456K | ﹤0.01% |
3,563
-91
| -2% | -$11.6K |
|
3009
EverCommerce
EVCM
$2.12B
| $453K | ﹤0.01% |
43,167
-166,912
| -79% | -$1.75M |
|
|
SARO
3010
StandardAero, Inc.
SARO
$9B
| $453K | ﹤0.01% |
14,309
+382
| +3% | +$12.1K |
|
3011
Inseego
INSG
$196M
| $450K | ﹤0.01% |
54,595
+4,590
| +9% | +$37.8K |
|
3012
Sutro Biopharma
STRO
$83.3M
| $449K | ﹤0.01% |
628,473
-189,006
| -23% | -$135K |
|
3013
Compass Therapeutics
CMPX
$590M
| $447K | ﹤0.01% |
172,227
+33,425
| +24% | +$86.8K |
|
3014
Airgain
AIRG
$51.3M
| $443K | ﹤0.01% |
106,708
+904
| +0.9% | +$3.75K |
|
3015
Farmer Brothers
FARM
$42.9M
| $434K | ﹤0.01% |
316,623
-14,958
| -5% | -$20.5K |
|
3016
Network-1 Technologies
NTIP
$36.9M
| $432K | ﹤0.01% |
353,978
| – | – |
|
|
JOYY
3017
JOYY Inc. American Depositary Shares
JOYY
$3.27B
| $427K | ﹤0.01% |
8,395
| – | – |
|
3018
Anavex Life Sciences
AVXL
$803M
| $423K | ﹤0.01% |
45,899
| – | – |
|
3019
Rigetti Computing
RGTI
$4.91B
| $419K | ﹤0.01% |
35,361
| – | – |
|
3020
First US Bancshares
FUSB
$69.3M
| $419K | ﹤0.01% |
32,479
| – | – |
|
3021
Gran Tierra Energy
GTE
$135M
| $418K | ﹤0.01% |
87,532
-63,954
| -42% | -$305K |
|
3022
CytomX Therapeutics
CTMX
$360M
| $416K | ﹤0.01% |
+183,166
| New | +$416K |
|
|
BORR
3023
Borr Drilling
BORR
$856M
| $407K | ﹤0.01% |
222,552
-123,078
| -36% | -$225K |
|
3024
W&T Offshore
WTI
$260M
| $407K | ﹤0.01% |
246,172
-250,966
| -50% | -$415K |
|
3025
AC Immune
ACIU
$221M
| $403K | ﹤0.01% |
198,686
-38,872
| -16% | -$78.9K |
|